Svennilson Peter

10% owner at Tenaya Therapeutics, Inc. · on record since Feb 26, 2026
10% owner at Surrozen, Inc./DE · on record since Jan 20, 2026
10% owner at Eikon Therapeutics, Inc. · on record since Feb 9, 2026
Director at IMMUNE DESIGN CORP. · on record since Jul 31, 2014
10% owner at IMMUNE DESIGN CORP. · on record since Jul 31, 2014
10% owner at Nurix Therapeutics, Inc. · on record since May 7, 2021
10% owner at Arcus Biosciences, Inc. · on record since Mar 19, 2018
Director at Gritstone bio, Inc. · on record since Sep 27, 2018
10% owner at Gritstone bio, Inc. · on record since Sep 27, 2018
Director at CONSTELLATION PHARMACEUTICALS INC · on record since Jul 23, 2018
10% owner at CONSTELLATION PHARMACEUTICALS INC · on record since Jul 23, 2018
Director at NGM BIOPHARMACEUTICALS INC · on record since Jun 26, 2019
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Jun 26, 2019
Director at Oric Pharmaceuticals, Inc. · on record since Apr 28, 2020
10% owner at Oric Pharmaceuticals, Inc. · on record since Apr 28, 2020
Director at RAPT Therapeutics, Inc. · on record since Jun 19, 2020
Director at Revolution Medicines, Inc. · on record since Jun 19, 2020
10% owner at Revolution Medicines, Inc. · on record since Jun 19, 2020
10% owner at · on record since Sep 7, 2021
10% owner at · on record since Jun 19, 2020

Insider trading activity of Svennilson Peter

Transactions on record: 217; since Jul 31, 2014

Open-market buys: 88; $84.8M

Open-market sells: 39; $118.6M

Companies traded: 9; last filing Dec 14, 2022

Figures computed from official regulatory filings — .

Companies where Svennilson Peter has traded

96 tx · $64.3M · Dec 14, 2022
30 tx · $34M · Aug 24, 2021
10 tx · Jun 17, 2021
15 tx · May 7, 2021
27 tx · $84.2M · Apr 28, 2021
10 tx · $416.2K · Feb 19, 2021
4 tx · Jun 20, 2019
8 tx · Mar 19, 2018
17 tx · $20.8M · Jan 8, 2018

Track record of Svennilson Peter

Open-market buys: 88

Last buy: Dec 12, 2022

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Svennilson Peter

Co-insiders of Svennilson Peter

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NGM BIOPHARMACEUTICALS INCListing unverified	Dec 14, 2022	Buy	300	4.98 USD	$1.5K	conv 25Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Nov 23, 2022	Buy	35,997	5.00 USD	$180K	conv 34Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Nov 23, 2022	Buy	4,330	5.00 USD	$21.7K	conv 25Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jun 6, 2022	Buy	1,129	13.03 USD	$14.7K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jun 6, 2022	Buy	33,071	13.03 USD	$430.9K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	60,583	13.20 USD	$799.7K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	86,110	13.42 USD	$1.2M	conv 34Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	2,067	13.20 USD	$27.3K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	2,939	13.42 USD	$39.4K	conv 31Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	241,750	—	n/a (No price was disclosed in the filing)	conv 72ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	8,250	—	n/a (No price was disclosed in the filing)	conv 72ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	579,910	—	n/a (No price was disclosed in the filing)	conv 66Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	19,791	—	n/a (No price was disclosed in the filing)	conv 66Cluster	SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-1,670	30.07 USD	$50.2K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-12,354	31.42 USD	$388.2K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-2,100	32.38 USD	$68K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-7,278	30.92 USD	$225K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-7,605	30.93 USD	$235.2K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-13,623	31.40 USD	$427.8K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-3,486	31.76 USD	$110.7K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-7,100	31.77 USD	$225.6K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-12,969	31.41 USD	$407.4K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-3,463	31.76 USD	$110K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-2,300	30.81 USD	$70.9K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-8,204	30.94 USD	$253.8K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NGM BIOPHARMACEUTICALS INCListing unverified	Dec 14, 2022	Buy	300	4.98 USD	$1.5K	conv 25Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Nov 23, 2022	Buy	35,997	5.00 USD	$180K	conv 34Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Nov 23, 2022	Buy	4,330	5.00 USD	$21.7K	conv 25Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jun 6, 2022	Buy	1,129	13.03 USD	$14.7K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jun 6, 2022	Buy	33,071	13.03 USD	$430.9K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	60,583	13.20 USD	$799.7K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	86,110	13.42 USD	$1.2M	conv 34Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	2,067	13.20 USD	$27.3K	conv 26Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 19, 2022	Buy	2,939	13.42 USD	$39.4K	conv 31Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	241,750	—	n/a (No price was disclosed in the filing)	conv 72ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	8,250	—	n/a (No price was disclosed in the filing)	conv 72ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	579,910	—	n/a (No price was disclosed in the filing)	conv 66Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 26, 2022	Buy	19,791	—	n/a (No price was disclosed in the filing)	conv 66Cluster	SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-1,670	30.07 USD	$50.2K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-12,354	31.42 USD	$388.2K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-2,100	32.38 USD	$68K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-7,278	30.92 USD	$225K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-7,605	30.93 USD	$235.2K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-13,623	31.40 USD	$427.8K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-3,486	31.76 USD	$110.7K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-7,100	31.77 USD	$225.6K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-12,969	31.41 USD	$407.4K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-3,463	31.76 USD	$110K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-2,300	30.81 USD	$70.9K		SEC
RAPT Therapeutics, Inc.Listing unverified	Aug 24, 2021	Sell	-8,204	30.94 USD	$253.8K		SEC